Tumor-Associated Macrophage Status in Cancer Treatment

被引:152
作者
Malfitano, Anna Maria [1 ]
Pisanti, Simona [2 ]
Napolitano, Fabiana [1 ]
Di Somma, Sarah [1 ]
Martinelli, Rosanna [2 ]
Portella, Giuseppe [1 ]
机构
[1] Univ Naples Federico II, Dept Translat Med Sci, I-80131 Naples, Italy
[2] Univ Salerno, Scuola Med Salernitana, Dept Med Surg & Dent, Via Salvador Allende, I-84081 Salerno, Italy
关键词
tumor-associated macrophages; chemotherapy; radiotherapy; immune-checkpoint blocking therapy; oncolytic virus; virotherapy; REGULATORY T-CELLS; ACTIVATED MACROPHAGES; IONIZING-RADIATION; PERITONEAL-MACROPHAGES; ONCOLYTIC VIROTHERAPY; PANCREATIC-CANCER; TNF-ALPHA; METASTASES; BREAST; INHIBITION;
D O I
10.3390/cancers12071987
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Tumor-associated macrophages (TAMs) represent the most abundant innate immune cells in tumors. TAMs, exhibiting anti-inflammatory phenotype, are key players in cancer progression, metastasis and resistance to therapy. A high TAM infiltration is generally associated with poor prognosis, but macrophages are highly plastic cells that can adopt either proinflammatory/antitumor or anti-inflammatory/protumor features in response to tumor microenvironment stimuli. In the context of cancer therapy, many anticancer therapeutics, apart from their direct effect on tumor cells, display different effects on TAM activation status and density. In this review, we aim to evaluate the indirect effects of anticancer therapies in the modulation of TAM phenotypes and pro/antitumor activity.
引用
收藏
页数:25
相关论文
共 127 条
[1]
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer [J].
Adams, Sylvia ;
Kozhaya, Lina ;
Martiniuk, Frank ;
Meng, Tze-Chiang ;
Chiriboga, Luis ;
Liebes, Leonard ;
Hochman, Tsivia ;
Shuman, Nicholas ;
Axelrod, Deborah ;
Speyer, James ;
Novik, Yelena ;
Tiersten, Amy ;
Goldberg, Judith D. ;
Formenti, Silvia C. ;
Bhardwaj, Nina ;
Unutmaz, Derya ;
Demaria, Sandra .
CLINICAL CANCER RESEARCH, 2012, 18 (24) :6748-6757
[2]
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment [J].
Allavena, P. ;
Mantovani, A. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 167 (02) :195-205
[3]
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses [J].
Anfray, Clement ;
Ummarino, Aldo ;
Torres Andon, Fernando ;
Allavena, Paola .
CELLS, 2020, 9 (01)
[4]
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity [J].
Angelova, Assia L. ;
Barf, Milena ;
Geletneky, Karsten ;
Unterberg, Andreas ;
Rommelaere, Jean .
VIRUSES-BASEL, 2017, 9 (12)
[5]
Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors [J].
Argyle, David ;
Kitamura, Takanori .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[6]
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy [J].
Arlauckas, Sean P. ;
Garris, Christopher S. ;
Kohler, Rainer H. ;
Kitaoka, Maya ;
Cuccarese, Michael F. ;
Yang, Katherine S. ;
Miller, Miles A. ;
Carlson, Jonathan C. ;
Freeman, Gordon J. ;
Anthony, Robert M. ;
Weissleder, Ralph ;
Pittet, Mikael J. .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (389)
[7]
New opportunities in a challenging disease: lurbinectedin for relapsed small-cell lung cancer [J].
Arrieta, Oscar ;
Lucia Zatarain-Barron, Zyanya ;
Cardona, Andres F. .
LANCET ONCOLOGY, 2020, 21 (05) :605-607
[8]
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity [J].
Baer, Caroline ;
Squadrito, Mario Leonardo ;
Laoui, Damya ;
Thompson, Danielle ;
Hansen, Sarah K. ;
Kiialainen, Anna ;
Hoves, Sabine ;
Ries, Carola H. ;
Ooi, Chia-Huey ;
De Palma, Michele .
NATURE CELL BIOLOGY, 2016, 18 (07) :790-+
[9]
Biology and therapeutic targeting of tumour-associated macrophages [J].
Beltraminelli, Tim ;
De Palma, Michele .
JOURNAL OF PATHOLOGY, 2020, 250 (05) :573-592
[10]
Metabolic Reprogramming of Immune Cells in Cancer Progression [J].
Biswas, Subhra K. .
IMMUNITY, 2015, 43 (03) :435-449